Scientific research on nutrition and natural approaches and resources in cancer. Studieabstracten study and analysis.

Here we list articles and studies or research on cancer in relation to nutrition. With some additional comments other as we found on the Internet. We will complement these articles regularly, but that takes time and we want very carefully. We have tried to research and articles in logical and more or less alphabetical order. Often an article in the name of nutrient - vitamin etc. But sometimes in diets or diet in cancer or cancer type out the first named, including bladder cancer and vitamins in the BA. So take the name of one nutrient or use search to start because of various cancers are also often important studies and articles that are not all in this list.

If there are people who can give us tips like please send us remarkable investigations and we post on the site. (See also reading list ( This list compiled by physician-biologist Erik Valstar has exceeded 1500 and are all randomized trials) and cancer rates ). In addition, a recommendation to information on proven effects of diet and nutritional supplementation in cancer of the book: Nutritional intervention in cancer, a signal to the conventional oncology. Because physician-biologist Dr Engelbert Valstar. The book costs 16.95 and the ISBN number is 90 5860 192 7.

In the left column we have posted articles on more or less alphabetical order. Sometimes the name of agent (eg Chinese herbs or form of treatment such as acupuncture or cancer such as colon cancer

Melanoma: Calcium plus vitamin D prevents 57% of women with a history of a form of non-melanoma skin cancer, basal skin cancer, yet a melanoma. This shows a 7-year randomized placebo-controlled study in women. Article posted July 6, 2011

July 6, 2011: Source: Journal of Clinical Oncology

Calcium plus vitamin D does significant preventive protective in women after menopause, a previously non-melanoma skin cancer have had in preventing the development of melanoma. This follows from the analysis of a subgroup of the Womans Health Study. A 7-year randomized placebo-controlled study in 36,282 women health. The overall study showed that calcium and vitamin D work would not be protective for the development of basal skin cancer or melanoma, but a subanalysis showed that a whopping 57% fewer women in the group of women who had a history of skin cancer and basal calcium and vitamin D not swallow developed melanoma compared with the group of women who do not swallow calcium and vitamin D, with a history of basal huiidkanker. The researchers argue for a separate follow-up study that examines a targeted this group of women. The researchers also have concerns with the required amounts of calcium and vitamin D for women who had no history of basal skin cancer. The investigators would like to give higher doses but can not because of the established guidelines for supplementation use in America.

For those who still want to calcium and vitamin D to consult before using a well-qualified orthomolecular doctor , they are allowed to prescribe higher doses. Here is the abstract of the study.

In women with history of NMSC, calcium and vitamin D supplementation reduced melanoma risk, suggests a potential role for calcium and vitamin D supplementation in this high risk group

Source: Journal of Oncology clinicl

Calcium Plus Vitamin D supplementation and the Risk of Melanoma and nonmelanoma Skin Cancer: Post Hoc Analysis of the Women's Health Initiative Randomized Controlled Trial

  1. Jean Y. Tang ⇓ ,
  2. Teresa Fu ,
  3. Erin LeBlanc ,
  4. JoAnn E. Manson ,
  5. David Feldman ,
  6. Eleni Linos ,
  7. Mara Z. Vitolins ,
  8. Nathalie C. Zeitouni ,
  9. Joseph Larson and
  10. Marcia L. Stefanick

+ Author Affiliations

  1. Jean Y. Tang, Teresa Fu, David Feldman, Eleni Linos, and Marcia L. Stefanick, Stanford School of Medicine, Stanford University, Stanford, CA, Erin LeBlanc, Northwest Kaiser Center for Health Research, Portland, JoAnn E. Manson, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, Mara Z. Vitolins, Wake Forest University Health Sciences, Winston-Salem, NC, Nathalie C. Zeitouni, Roswell Park Cancer Institute and University at Buffalo, NY, and Joseph Larson, Women's Health Initiative Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA.
  1. Corresponding author Ding: Jean Y. Tang, MD, PhD, Department of Dermatology, Stanford University School of Medicine, 450 Broadway, Pavilion C, MC 5334, Redwood City, CA 94305, email: tangy@stanford.edu .

Abstract

Purpose in light or inverse relationships reported in observational studies of vitamin D intake and serum 25-hydroxyvitamin D levels with risk of nonmelanoma skin cancer (NMSC) and melanoma, we Evaluated the effects of vitamin D combined with calcium supplementation on skin cancer in a randomized placebo-controlled trial.

Methods postmenopausal women age 50 to 79 years (N = 36,282) enrolled onto the Women's Health Initiative (WHI) calcium / vitamin D clinical trial were randomly Assigned to receive 1000 mg of elemental calcium plus 400 IU of vitamin D3 (CAD) daily or placebo for a mean follow up period of 7.0 years. NMSC and melanoma skin cancers were ascertained by annual self-report; melanoma skin cancers physician went under adjudication.

Results Neither NMSC nor melanoma incident rates differed Between treatment (hazard ratio [HR], 1.02, 95% CI, 0.95 to 1.07) and placebo groups (HR 0.86, 95% CI, 0.64 to 1.16). In subgroup analysis, women with history of NMSC Assigned to CAD had a reduced risk of melanoma versus Those Receiving placebo (HR 0.43, 95% CI, 0.21 to 0.90, P interaction = .038), All which was not observed in women without history or NMSC.

Conclusion Vitamin D supplementation at a Relatively low dose plus calcium did not reducing the overall incidence of NMSC or melanoma. However, in women with history of NMSC, CAD supplementation reduced melanoma risk, suggests a potential role for calcium and vitamin D supplementation in this high-risk group. Results from this post hoc subgroup analysis Should Be Interpreted with caution but Additional investigation warrants.